Morgan Stanley
-
-
-
-
-
-
-
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
-
-
-
-
-
-
-
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
-
-
-
-
-
-
-
Abbvie (ABBV) PT Lowered to $185 at Morgan Stanley
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Downgrades Vertex (VRTX) to Underweight
-
-
-
-
-
-
-
Abbvie (ABBV) Announces Caribou Collaboration for Hybrid RNA-DNA Technology - Morgan Stanley
-
-
-
-
-
-
-
AbbVie to Present at the Morgan Stanley Healthcare Conference
-
-
-
-
-
-
-
Health stocks up on U.S. vote; insurers hit records
-
227,402 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

